SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 22, 1999
BERGEN BRUNSWIG CORPORATION
________________________________________________________________________________
(Exact Name of Registrant as Specified in Charter)
New Jersey 1-5110 22-1444512
________________ _____________ __________________
(State Or Other (Commission (IRS Employer
Jurisdiction Of File Number) Identification No.)
Incorporation)
4000 Metropolitan Drive, Orange, California 92868
_______________________________________________ ___________
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (714) 385-4000
<PAGE>
Item 5. Other Events.
On January 22, 1999, Bergen Brunswig Corporation completed its
previously announced acquisition of the business of Stadtlander Drug Co., Inc.,
from Stadt Holdings Inc., an indirect wholly-owned subsidiary of Counsel
Corporation.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BERGEN BRUNSWIG CORPORATION
By: /s/ Milan A. Sawdei
________________________
Milan A. Sawdei
Executive Vice President
Chief Legal Officer and Secretary
Date: January 25, 1999
